Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT01355484 · COMPLETED

Trial details

NCT number: NCT01355484
Sponsor: GTx
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Muscle Wasting Non Small Cell Lung Cancer

Start date: 2011-07-01
Primary completion: 2013-05-01
Enrollment: 321

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.